Tempest Therapeutics Newsroom

Tempest Therapeutics Is Maintained at Overweight by Piper Sandler

Dow JonesNov 13 12:00 ET

Piper Sandler Maintains Tempest Therapeutics(TPST.US) With Buy Rating, Cuts Target Price to $5

Moomoo NewsNov 13 08:34 ET

Scotiabank Reaffirms Their Buy Rating on Tempest Therapeutics (TPST)

TipRanksNov 13 07:36 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Quanterix (QTRX), Nevro Corp (NVRO) and Tempest Therapeutics (TPST)

TipRanksNov 13 07:34 ET

Tempest Therapeutics Analyst Ratings

BenzingaNov 13 07:26 ET

HC Wainwright & Co. Reiterates Buy on Tempest Therapeutics, Maintains $47 Price Target

BenzingaNov 13 07:26 ET

Tempest Therapeutics: Promising Advancements and Strategic Partnerships Justify Buy Rating

TipRanksNov 13 06:39 ET

Scotiabank Sticks to Their Buy Rating for Tempest Therapeutics (TPST)

TipRanksOct 11 07:37 ET

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Allakos (ALLK) and Tempest Therapeutics (TPST)

TipRanksOct 11 07:35 ET

Tempest Therapeutics Analyst Ratings

BenzingaOct 10 13:42 ET

HC Wainwright & Co. Reiterates Buy on Tempest Therapeutics, Maintains $47 Price Target

BenzingaOct 10 13:42 ET

Buy Rating Affirmed for Tempest Therapeutics Amid Positive Developments and Strategic Roche Collaboration

TipRanksOct 10 11:27 ET

Scotiabank Maintains Tempest Therapeutics(TPST.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsAug 16 08:34 ET

Scotiabank Keeps Their Buy Rating on Tempest Therapeutics (TPST)

TipRanksAug 16 07:37 ET

Tempest Therapeutics Analyst Ratings

BenzingaAug 15 12:44 ET

Buy Rating Affirmed for Tempest Therapeutics Amidst Promising Phase 3 Outlook and Funding Uncertainties

TipRanksAug 15 09:09 ET

Scotiabank Sticks to Their Buy Rating for Tempest Therapeutics (TPST)

TipRanksAug 9 08:46 ET

Buy Rating Affirmed for Tempest Therapeutics Amid Strong Clinical Results and Solid Financials

TipRanksAug 9 07:20 ET

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), CVS Health (CVS) and Tempest Therapeutics (TPST)

TipRanksJul 27 05:08 ET

Tempest Therapeutics Analyst Ratings

BenzingaMay 13 08:07 ET